OTC · MSGP
MedSmart Group Inc.
$0.00$0.00 (0.0%)
MedSmart Group Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · SCIE · USD
Stock price, earnings
Quote as of Aug 26, 2025, 05:03 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
SpectraScience, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow SpectraScience, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SpectraScience, Inc. specializes in creating and distributing an advanced technological platform designed for the immediate classification of tissue as normal, pre-cancerous, or cancerous, thereby bypassing the requirement for invasive physical biopsies. This innovative approach is accessible in the United States, Europe, and other global regions. The company's product line includes the WavSTAT3 optical biopsy system, which assesses colon tissue for normal, pre-cancerous, or cancerous conditions without surgical removal. Another key offering is the WavSTAT4 optical biopsy system, a diagnostic tool for the colon that employs UV laser light to optically scan and analyze tissue, enabling physicians to make instant diagnoses during endoscopic cancer screenings. Additionally, SpectraScience provides related accessories such as mobile consoles and disposable forceps. The company is also actively developing an application for esophageal diagnostics, focused on identifying pre-cancerous and cancerous tissue formations. Founded in 1983, the company operated as GV Medical, Inc. until it adopted the name SpectraScience, Inc. in October 1992, and is headquartered in San Diego, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:23 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
MedSmart Group Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Better Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Inyx, Inc.: Healthcare · Medical - Pharmaceuticals.
$0.00$0.00 (0.0%)
Arno Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Sunridge International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.49% below the high.
$0.00$0.00 (0.0%)
Viveve Medical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
Dermisonics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
IMRIS Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.1% below the high.
